Literature DB >> 28911042

Novel Agents and Drug Targets to Meet the Challenges of Resistant Fungi.

Matthew W McCarthy1, Dimitrios P Kontoyiannis2, Oliver A Cornely3, John R Perfect4, Thomas J Walsh5.   

Abstract

The emergence of drug-resistant fungi poses a major threat to human health. Despite advances in preventive, diagnostic, and therapeutic interventions, resistant fungal infections continue to cause significant morbidity and mortality in patients with compromised immunity, underscoring the urgent need for new antifungal agents. In this article, we review the challenges associated with identifying broad-spectrum antifungal drugs and highlight novel targets that could enhance the armamentarium of agents available to treat drug-resistant invasive fungal infections.
© The Author 2017. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  E1210; chelator; dihydroorotate dehydrogenase; epigenetic; glycosphingolipids; glycosylphosphatidylinositol; transcription factors

Mesh:

Substances:

Year:  2017        PMID: 28911042     DOI: 10.1093/infdis/jix130

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  41 in total

1.  Drosophila melanogaster as a model to study virulence and azole treatment of the emerging pathogen Candida auris.

Authors:  Sebastian Wurster; Ashwini Bandi; Nicholas D Beyda; Nathaniel D Albert; Nitya M Raman; Isaam I Raad; Dimitrios P Kontoyiannis
Journal:  J Antimicrob Chemother       Date:  2019-07-01       Impact factor: 5.790

Review 2.  Epigenetic mechanisms of drug resistance in fungi.

Authors:  Zanetta Chang; Vikas Yadav; Soo Chan Lee; Joseph Heitman
Journal:  Fungal Genet Biol       Date:  2019-07-17       Impact factor: 3.495

3.  Invasive Fungal Infection.

Authors:  Marie von Lilienfeld-Toal; Johannes Wagener; Hermann Einsele; Oliver A Cornely; Oliver Kurzai
Journal:  Dtsch Arztebl Int       Date:  2019-04-19       Impact factor: 5.594

4.  Antifungal Activity of Gepinacin Scaffold Glycosylphosphatidylinositol Anchor Biosynthesis Inhibitors with Improved Metabolic Stability.

Authors:  Sean D Liston; Luke Whitesell; Catherine A McLellan; Ralph Mazitschek; Vidmantas Petraitis; Ruta Petraitiene; Povilas Kavaliauskas; Thomas J Walsh; Leah E Cowen
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

5.  How I transplant a patient with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-08-26       Impact factor: 22.113

Review 6.  Therapeutic Challenges of Non-Aspergillus Invasive Mold Infections in Immunosuppressed Patients.

Authors:  Frederic Lamoth; Dimitrios P Kontoyiannis
Journal:  Antimicrob Agents Chemother       Date:  2019-10-22       Impact factor: 5.191

7.  Alkylated Piperazines and Piperazine-Azole Hybrids as Antifungal Agents.

Authors:  Nishad Thamban Chandrika; Sanjib K Shrestha; Huy X Ngo; Oleg V Tsodikov; Kaitlind C Howard; Sylvie Garneau-Tsodikova
Journal:  J Med Chem       Date:  2017-12-19       Impact factor: 7.446

Review 8.  Aspergillus fumigatus and Aspergillosis in 2019.

Authors:  Jean-Paul Latgé; Georgios Chamilos
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

9.  How I perform hematopoietic stem cell transplantation on patients with a history of invasive fungal disease.

Authors:  Pedro Puerta-Alcalde; Richard E Champlin; Dimitrios P Kontoyiannis
Journal:  Blood       Date:  2020-12-10       Impact factor: 22.113

10.  Enantioselective Synthesis of (+)-Hippolide J and Reevaluation of Antifungal Activity.

Authors:  Renyu Guo; Sarah R Beattie; Damian J Krysan; M Kevin Brown
Journal:  Org Lett       Date:  2020-09-24       Impact factor: 6.005

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.